Dynamic Technology Lab Private Ltd bought a new position in shares of Genpact Limited (NYSE:G) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 8,365 shares of the business services provider’s stock, valued at approximately $240,000.
A number of other large investors have also recently modified their holdings of the business. Alps Advisors Inc. grew its position in Genpact by 0.3% in the second quarter. Alps Advisors Inc. now owns 20,129 shares of the business services provider’s stock valued at $560,000 after acquiring an additional 52 shares in the last quarter. Bronfman E.L. Rothschild L.P. grew its position in Genpact by 1.9% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 5,053 shares of the business services provider’s stock valued at $141,000 after acquiring an additional 94 shares in the last quarter. Sawtooth Solutions LLC grew its position in Genpact by 1.9% in the second quarter. Sawtooth Solutions LLC now owns 9,034 shares of the business services provider’s stock valued at $251,000 after acquiring an additional 165 shares in the last quarter. YorkBridge Wealth Partners LLC grew its position in Genpact by 5.2% in the second quarter. YorkBridge Wealth Partners LLC now owns 3,793 shares of the business services provider’s stock valued at $106,000 after acquiring an additional 189 shares in the last quarter. Finally, The Manufacturers Life Insurance Company grew its position in Genpact by 7.5% in the second quarter. The Manufacturers Life Insurance Company now owns 6,508 shares of the business services provider’s stock valued at $181,000 after acquiring an additional 455 shares in the last quarter. 91.16% of the stock is owned by institutional investors.
Several equities analysts have recently commented on G shares. Robert W. Baird reiterated a “buy” rating and set a $38.00 target price on shares of Genpact in a research note on Friday, November 10th. Zacks Investment Research upgraded Genpact from a “sell” rating to a “hold” rating and set a $35.00 target price for the company in a research note on Friday, November 10th. Cantor Fitzgerald reiterated a “buy” rating and set a $36.00 target price on shares of Genpact in a research note on Wednesday, November 8th. Cowen reiterated a “buy” rating and set a $33.00 target price on shares of Genpact in a research note on Thursday, October 12th. Finally, SunTrust Banks reiterated a “buy” rating and set a $34.00 target price on shares of Genpact in a research note on Monday, October 9th. Three investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $33.38.
In related news, insider Mohit Thukral sold 25,000 shares of Genpact stock in a transaction dated Tuesday, November 28th. The stock was sold at an average price of $32.25, for a total transaction of $806,250.00. Following the transaction, the insider now directly owns 85,305 shares of the company’s stock, valued at $2,751,086.25. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Piyush Mehta sold 20,728 shares of Genpact stock in a transaction dated Thursday, October 26th. The stock was sold at an average price of $30.00, for a total value of $621,840.00. The disclosure for this sale can be found here. Insiders have sold 1,575,051 shares of company stock worth $47,739,747 over the last three months. Corporate insiders own 1.41% of the company’s stock.
Shares of Genpact Limited (G) traded down $0.21 during midday trading on Thursday, reaching $31.95. The company’s stock had a trading volume of 1,304,400 shares, compared to its average volume of 1,040,368. Genpact Limited has a 1 year low of $23.34 and a 1 year high of $32.51. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.65 and a quick ratio of 1.65. The firm has a market capitalization of $6,208.24, a price-to-earnings ratio of 20.88, a PEG ratio of 2.20 and a beta of 0.58.
Genpact (NYSE:G) last issued its earnings results on Tuesday, November 7th. The business services provider reported $0.46 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.36 by $0.10. Genpact had a return on equity of 23.86% and a net margin of 10.18%. The firm had revenue of $708.82 million for the quarter, compared to analyst estimates of $685.25 million. During the same period last year, the company earned $0.37 earnings per share. The firm’s revenue for the quarter was up 9.3% on a year-over-year basis. equities research analysts predict that Genpact Limited will post 1.47 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 20th. Stockholders of record on Friday, December 8th will be issued a dividend of $0.06 per share. This represents a $0.24 dividend on an annualized basis and a dividend yield of 0.75%. The ex-dividend date is Thursday, December 7th. Genpact’s dividend payout ratio (DPR) is 17.39%.
ILLEGAL ACTIVITY WARNING: This news story was first posted by Transcript Daily and is the property of of Transcript Daily. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The legal version of this news story can be read at https://transcriptdaily.com/2017/12/07/dynamic-technology-lab-private-ltd-buys-shares-of-8365-genpact-limited-g.html.
Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.
Receive News & Ratings for Genpact Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact Limited and related companies with MarketBeat.com's FREE daily email newsletter.